CME Group Reaches New 1-Year High After Analyst Upgrade

Stock price surges on positive outlook from Goldman Sachs

Published on Feb. 12, 2026

Got story updates? Submit your updates here. ›

CME Group Inc. (NASDAQ:CME), the global markets company that operates major derivatives exchanges, saw its stock price reach a new 52-week high after investment bank The Goldman Sachs Group raised its price target on the company's shares. The upgrade comes as CME Group continues to benefit from strong trading volumes and demand for its electronic trading, clearing, and market data services.

Why it matters

CME Group is a bellwether for the broader derivatives and financial services industry. Its performance is closely watched as an indicator of overall market conditions and investor sentiment. The analyst upgrade and new 52-week high suggest growing confidence in CME Group's ability to navigate the current economic environment and capitalize on market trends.

The details

The Goldman Sachs Group increased its price target on CME Group from $264 to $266, while maintaining a 'sell' rating on the stock. CME Group's shares traded as high as $307.84 on Tuesday, closing at $307.24 with trading volume of over 2.3 million shares. The stock's previous 52-week high was $302.27. Several other analysts have also issued positive reports on CME Group in recent months, with Morgan Stanley raising its price target to $340 and Weiss Ratings reaffirming a 'buy' rating.

  • CME Group's stock price reached a new 52-week high on Tuesday, February 12, 2026.
  • The Goldman Sachs Group raised its price target on CME Group on February 12, 2026.

The players

CME Group Inc.

A global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX.

The Goldman Sachs Group

A leading global investment banking, securities and investment management firm that raised its price target on CME Group's stock.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

The takeaway

The new 52-week high for CME Group's stock price and the positive analyst outlook underscore the company's resilience and ability to capitalize on market trends, even in a challenging economic environment. As a leading global derivatives exchange operator, CME Group's performance is a key indicator of broader financial market conditions.